4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation

Compound 53 was identified to be potent GyrB inhibitor with 0.86 μM and an MIC of 3.3 μM